Kalyan Roy: The Oxygen Delivery Paradox in Polycythaemia Vera
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“The Oxygen Delivery Paradox in Polycythaemia Vera (PV)
At first glance, a higher hematocrit appears beneficial because it increases red blood cell mass and total oxygen content. However, the physiology is more complex.
What Happens When Hematocrit Rises?
- Increased hematocrit or increased red blood cell mass
- Leads to Increased Blood Viscosity
- Which leads to Reduced microcirculatory blood flow
- Which results in Reduced tissue perfusion and oxygen delivery
- Leading to Increased endothelial activation
- Which increases The risk of arterial and venous thrombosis
Key Message
More RBCs mean More Oxygen Content
But not necessarily better oxygen delivery
As blood becomes more viscous, capillary flow and tissue perfusion decline. The result is a paradox where oxygen content rises while oxygen delivery to tissues may actually fall.
Clinical Relevance in PV
- Hyperviscosity is a major driver of symptoms and thrombosis.
- Maintaining hematocrit lower than 45% improves microcirculatory flow and reduces thrombotic complications.
- The goal of treatment is not simply to lower hematocrit, but to optimize tissue oxygen delivery and vascular health.
In Polycythaemia Vera, the problem is often not oxygen carrying capacity – it is impaired oxygen delivery due to hyperviscosity.”
Find more posts featuring Kalyan Roy on Hemostasis Today.
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits
-
Aug 5, 2026, 19:39Platelet-Derived Extracellular Vesicles for Hemostasis and Bleeding Reduction in TBI – Every Labs
-
Aug 5, 2026, 19:05Alfonso J. Tafur: Thromboinflammation and Hemostatic Dysfunction as Predictors of Early Pulmonary Embolism Mortality
-
Aug 5, 2026, 19:00Grigoris Gerotziafas: DU T2H 2026–2027 Enrolment Is Now Open
-
Aug 5, 2026, 19:00Konstantin Stark: Now Recruiting for the DFG Collaborative Research Center 1784
-
Aug 5, 2026, 18:59Should Genotype Guide Thromboprophylaxis in Pregnant Women With Antithrombin Deficiency? – RPTH Journal
-
Aug 5, 2026, 18:59Ayisha Munavar: Understanding PNH – A Rare Disease That Demands Early Recognition